Pub Date : 2026-02-03eCollection Date: 2026-01-01DOI: 10.3389/fcimb.2026.1746541
Xiaorong Peng, Yunan Chang, Jiaying Wu, Jing Zhu, Peng Hu, Hong Ren, Hongmei Xu, Ruiqiu Zhao, Tao Qin
Background: Serum hepatitis B virus (HBV) pregenomic RNA (pgRNA) predicts antiviral response in adults with chronic hepatitis B (CHB); however, its prognostic performance against conventional biomarkers in children remains underexplored. This study aimed to characterize the kinetics of pgRNA and hepatitis B surface antigen (HBsAg) and evaluate their predictive value for treatment outcomes in children with CHB.
Methods: Sixty-five hepatitis B e antigen (HBeAg)-positive children with CHB who received ≥ 96 weeks of nucleos(t)ide analogue (NA) therapy were included. Serum viral biomarkers were measured at baseline, weeks 12, 48, and 96. Treatment outcomes were HBeAg seroconversion and HBsAg loss (Defined as HBsAg <100 IU/mL or seroclearance).
Results: Patients initiating treatment before age 7 years had a significantly higher cumulative incidence of HBeAg seroconversion (73.5% vs. 48.4%) and HBsAg loss (50.0% vs. 9.7%) compared to older children (p < 0.05). Week 12 HBV pgRNA decline was an independent predictor of HBeAg seroconversion (area under the curve [AUC] = 0.793, 95% confidence interval [CI]: 0.686-0.900), outperforming HBV DNA and HBsAg kinetics. For predicting HBsAg loss, the week 12 HBsAg decline was an independent predictor (AUC = 0.762, 95% CI: 0.632-0.893), and its integration with patient age further improved predictive accuracy (AUC = 0.879, 95% CI: 0.796-0.962).
Conclusions: Early pgRNA kinetics more accurately predict HBeAg seroconversion, whereas HBsAg dynamics forecast HBsAg loss more effectively, particularly when combined with patient age. This complementary monitoring strategy provides a clinically applicable tool for optimizing personalized management in children with CHB.
{"title":"Hepatitis B virus RNA and hepatitis B surface antigen kinetics predict treatment outcomes in children with chronic hepatitis B.","authors":"Xiaorong Peng, Yunan Chang, Jiaying Wu, Jing Zhu, Peng Hu, Hong Ren, Hongmei Xu, Ruiqiu Zhao, Tao Qin","doi":"10.3389/fcimb.2026.1746541","DOIUrl":"https://doi.org/10.3389/fcimb.2026.1746541","url":null,"abstract":"<p><strong>Background: </strong>Serum hepatitis B virus (HBV) pregenomic RNA (pgRNA) predicts antiviral response in adults with chronic hepatitis B (CHB); however, its prognostic performance against conventional biomarkers in children remains underexplored. This study aimed to characterize the kinetics of pgRNA and hepatitis B surface antigen (HBsAg) and evaluate their predictive value for treatment outcomes in children with CHB.</p><p><strong>Methods: </strong>Sixty-five hepatitis B e antigen (HBeAg)-positive children with CHB who received ≥ 96 weeks of nucleos(t)ide analogue (NA) therapy were included. Serum viral biomarkers were measured at baseline, weeks 12, 48, and 96. Treatment outcomes were HBeAg seroconversion and HBsAg loss (Defined as HBsAg <100 IU/mL or seroclearance).</p><p><strong>Results: </strong>Patients initiating treatment before age 7 years had a significantly higher cumulative incidence of HBeAg seroconversion (73.5% vs. 48.4%) and HBsAg loss (50.0% vs. 9.7%) compared to older children (<i>p</i> < 0.05). Week 12 HBV pgRNA decline was an independent predictor of HBeAg seroconversion (area under the curve [AUC] = 0.793, 95% confidence interval [CI]: 0.686-0.900), outperforming HBV DNA and HBsAg kinetics. For predicting HBsAg loss, the week 12 HBsAg decline was an independent predictor (AUC = 0.762, 95% CI: 0.632-0.893), and its integration with patient age further improved predictive accuracy (AUC = 0.879, 95% CI: 0.796-0.962).</p><p><strong>Conclusions: </strong>Early pgRNA kinetics more accurately predict HBeAg seroconversion, whereas HBsAg dynamics forecast HBsAg loss more effectively, particularly when combined with patient age. This complementary monitoring strategy provides a clinically applicable tool for optimizing personalized management in children with CHB.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"16 ","pages":"1746541"},"PeriodicalIF":4.8,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12909504/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146217936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-02eCollection Date: 2025-01-01DOI: 10.3389/fcimb.2025.1653380
Sisi Chen, Shahid Ullah Khan, Safir Ullah Khan, Mohammed Alissa, Essam H Ibrahim, Saleem Ahmad, Ramadan Taha, Kun Zhou
Thyroid dysfunction is a common endocrine disease among women of childbearing age, which seriously affects reproductive health. From an immunological perspective, this in-depth analysis clarifies the complex relationship between thyroid function and female reproduction. We studied the hypothalamic-pituitary-gonadal axis regulation by thyroid hormones through direct and indirect mechanisms, including metabolic mediators such as prolactin and leptin. Recent studies have shown that inflammatory cytokines (IL-1α, IL-1β, IL-6, IFN-γ, and TNF-α) severely disrupt the production pathways of thyroid hormones, establishing an essential link between immune activation and reproductive problems. Since the placenta serves as an active immune interface affected by thyroid activity, there are significant physiological obstacles (including increased iodine clearance and elevated deiodinase activity), immunological challenges (such as altered cytokine profiles), and pathological barriers to optimal thyroid adaptation during pregnancy. This literature review indicates that thyroid problems substantially affect reproductive outcomes by altering the immune response at the maternal-fetal interface, influencing placental development, trophoblast invasion, and vascular remodeling. This review addresses a notable research deficiency through a modern perspective on thyroid dysfunction and reproductive issues, especially inflammatory cytokines related to preeclampsia. We believe that thyroid dysfunction can alter the expression of specific angiogenic factors (including sFlt-1, PlGF, and VEGF) and modify the immune cell profile at the maternal-fetal interface (particularly NK cells, macrophages, and T regulatory cells), creating a new framework for understanding and addressing thyroid-related reproductive diseases through targeted immunomodulatory strategies.
{"title":"Thyroid-reproductive axis interplay: immunological mechanisms and implications for female reproductive health.","authors":"Sisi Chen, Shahid Ullah Khan, Safir Ullah Khan, Mohammed Alissa, Essam H Ibrahim, Saleem Ahmad, Ramadan Taha, Kun Zhou","doi":"10.3389/fcimb.2025.1653380","DOIUrl":"https://doi.org/10.3389/fcimb.2025.1653380","url":null,"abstract":"<p><p>Thyroid dysfunction is a common endocrine disease among women of childbearing age, which seriously affects reproductive health. From an immunological perspective, this in-depth analysis clarifies the complex relationship between thyroid function and female reproduction. We studied the hypothalamic-pituitary-gonadal axis regulation by thyroid hormones through direct and indirect mechanisms, including metabolic mediators such as prolactin and leptin. Recent studies have shown that inflammatory cytokines (IL-1α, IL-1β, IL-6, IFN-γ, and TNF-α) severely disrupt the production pathways of thyroid hormones, establishing an essential link between immune activation and reproductive problems. Since the placenta serves as an active immune interface affected by thyroid activity, there are significant physiological obstacles (including increased iodine clearance and elevated deiodinase activity), immunological challenges (such as altered cytokine profiles), and pathological barriers to optimal thyroid adaptation during pregnancy. This literature review indicates that thyroid problems substantially affect reproductive outcomes by altering the immune response at the maternal-fetal interface, influencing placental development, trophoblast invasion, and vascular remodeling. This review addresses a notable research deficiency through a modern perspective on thyroid dysfunction and reproductive issues, especially inflammatory cytokines related to preeclampsia. We believe that thyroid dysfunction can alter the expression of specific angiogenic factors (including sFlt-1, PlGF, and VEGF) and modify the immune cell profile at the maternal-fetal interface (particularly NK cells, macrophages, and T regulatory cells), creating a new framework for understanding and addressing thyroid-related reproductive diseases through targeted immunomodulatory strategies.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"15 ","pages":"1653380"},"PeriodicalIF":4.8,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12907443/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146212653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Shewanella species (Shewanella spp.) were emerging and rare pathogens. Very few studies had focused on Shewanella spp. infection due to its low incidence. A retrospective analysis summarizing clinical and laboratory characteristics of Shewanella spp. infection at a tertiary hospital in Hefei City was conducted to learn more about the rare bacterium.
Methods: A total of 36 patients with Shewanella spp. infection from October 2019 to February 2025 were included. The data of all patients were collected by reviewing electronic records.
Results: Among 36 isolated strains, 77.8% were Shewanella algae and 22.2% were Shewanella putrefaciens. Abdominal pain was the most common clinical symptom. Intrahepatic stone and cholangitis was the main diagnosed disease. According to the type of main diagnosed disease, they were divided into two groups: hepatobiliary disease group and non-hepatobiliary disease group. The laboratory results were analyzed, and it was revealed that the laboratory characteristics of anemia, neutrophilia, leukocytosis, and so on were common. Serum coagulation tests results showed that it was significantly higher than the normal value, and all other serum biochemical and coagulation tests results were mostly normal. For microorganism culture, co-infection microorganisms were obtained. Shewanella spp. were usually susceptible to aminoglycoside, quinolone, cephalosporin, carbapenems, and compound antibiotics. All patients were treated with antibiotics, and there were one or more types of antibiotics to use, all of whom had effective treatment outcomes.
Discussion: Shewanella spp. infections were very limited. The study might improve the attention and awareness of the rare bacterial infection.
{"title":"Clinical and laboratory characteristics of patients infected with <i>Shewanella</i> species at a tertiary hospital in Hefei City, China: a retrospective analysis.","authors":"Xiangyun Li, Xiaoqin Deng, Jun Xu, Boke Zhang, Xinyu Yan, Yuanhong Xu","doi":"10.3389/fcimb.2026.1700922","DOIUrl":"https://doi.org/10.3389/fcimb.2026.1700922","url":null,"abstract":"<p><strong>Introduction: </strong><i>Shewanella</i> species (<i>Shewanella</i> spp.) were emerging and rare pathogens. Very few studies had focused on <i>Shewanella</i> spp. infection due to its low incidence. A retrospective analysis summarizing clinical and laboratory characteristics of <i>Shewanella</i> spp. infection at a tertiary hospital in Hefei City was conducted to learn more about the rare bacterium.</p><p><strong>Methods: </strong>A total of 36 patients with <i>Shewanella</i> spp. infection from October 2019 to February 2025 were included. The data of all patients were collected by reviewing electronic records.</p><p><strong>Results: </strong>Among 36 isolated strains, 77.8% were <i>Shewanella algae</i> and 22.2% were <i>Shewanella putrefaciens</i>. Abdominal pain was the most common clinical symptom. Intrahepatic stone and cholangitis was the main diagnosed disease. According to the type of main diagnosed disease, they were divided into two groups: hepatobiliary disease group and non-hepatobiliary disease group. The laboratory results were analyzed, and it was revealed that the laboratory characteristics of anemia, neutrophilia, leukocytosis, and so on were common. Serum coagulation tests results showed that it was significantly higher than the normal value, and all other serum biochemical and coagulation tests results were mostly normal. For microorganism culture, co-infection microorganisms were obtained. <i>Shewanella</i> spp. were usually susceptible to aminoglycoside, quinolone, cephalosporin, carbapenems, and compound antibiotics. All patients were treated with antibiotics, and there were one or more types of antibiotics to use, all of whom had effective treatment outcomes.</p><p><strong>Discussion: </strong><i>Shewanella</i> spp. infections were very limited. The study might improve the attention and awareness of the rare bacterial infection.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"16 ","pages":"1700922"},"PeriodicalIF":4.8,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12907408/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146212710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objectives: Although Diphtheria-Tetanus-acellular Pertussis (DTaP) vaccines have been used in the U.S. for decades and have extensive safety records, a comprehensive post-marketing assessment for all available types is still needed. This study leveraged the Vaccine Adverse Event Reporting System (VAERS) database to evaluate adverse events following immunization (AEFI) and analyze potential associations with vaccine administration.
Methods: We extracted all reports of adverse events (AEs) following DTaP vaccination from the VAERS database for the period 1990 to May 2025. Our analysis included descriptive statistics to summarize patient demographics and clinical features, and disproportionality methods to identify potential safety signals.
Results: During the study period, the VAERS database documented 57,341 children under 7 years who received DTaP vaccines, corresponding to 57,368 administered doses and 193,955 adverse event (AE) reports. AE reporting was more frequent in males (52.46%) than females (45.07%), with more than half of the cases (50.44%) involving children under 2 years old. The most common clinical outcomes were recovery (62.53%) and hospitalization (10.29%). Most AEs (89.61%) occurred within 0-30 days after vaccination, with a median onset time of 1.0 days. Infanrix (37.95%) and Daptacel (25.04%) were the most frequently reported vaccine types. Disproportionality analysis detected 158 positive AE signals across 24 system organ classes (SOCs). Among all SAEs, pyrexia (ROR = 1.01) was the most frequently reported, followed by convulsion (ROR = 1.82) and vomiting (ROR = 1.05). The most common signals for non-SAEs included injection site erythema (ROR = 3.79), injection site swelling (ROR = 3.00), and erythema (ROR = 3.03).
Conclusions: This post-marketing surveillance indicates that most reported AEs were non-serious and occurred within 30 days following vaccination. These findings support the known safety profile of DTaP vaccines and highlight identifiable timing patterns of AEs, which may help inform monitoring strategies and benefit-risk assessments after immunization.
{"title":"Diphtheria-tetanus-acellular pertussis vaccine safety in children under 7 years: a post-marketing analysis of the U.S. vaccine adverse event reporting system.","authors":"Meishen Liu, Xueying Zhou, Linshu Guan, Hening Sun, Zhaohui Bai, Yalin Xi, Xinkuo Zheng","doi":"10.3389/fcimb.2026.1733777","DOIUrl":"https://doi.org/10.3389/fcimb.2026.1733777","url":null,"abstract":"<p><strong>Objectives: </strong>Although Diphtheria-Tetanus-acellular Pertussis (DTaP) vaccines have been used in the U.S. for decades and have extensive safety records, a comprehensive post-marketing assessment for all available types is still needed. This study leveraged the Vaccine Adverse Event Reporting System (VAERS) database to evaluate adverse events following immunization (AEFI) and analyze potential associations with vaccine administration.</p><p><strong>Methods: </strong>We extracted all reports of adverse events (AEs) following DTaP vaccination from the VAERS database for the period 1990 to May 2025. Our analysis included descriptive statistics to summarize patient demographics and clinical features, and disproportionality methods to identify potential safety signals.</p><p><strong>Results: </strong>During the study period, the VAERS database documented 57,341 children under 7 years who received DTaP vaccines, corresponding to 57,368 administered doses and 193,955 adverse event (AE) reports. AE reporting was more frequent in males (52.46%) than females (45.07%), with more than half of the cases (50.44%) involving children under 2 years old. The most common clinical outcomes were recovery (62.53%) and hospitalization (10.29%). Most AEs (89.61%) occurred within 0-30 days after vaccination, with a median onset time of 1.0 days. Infanrix (37.95%) and Daptacel (25.04%) were the most frequently reported vaccine types. Disproportionality analysis detected 158 positive AE signals across 24 system organ classes (SOCs). Among all SAEs, pyrexia (ROR = 1.01) was the most frequently reported, followed by convulsion (ROR = 1.82) and vomiting (ROR = 1.05). The most common signals for non-SAEs included injection site erythema (ROR = 3.79), injection site swelling (ROR = 3.00), and erythema (ROR = 3.03).</p><p><strong>Conclusions: </strong>This post-marketing surveillance indicates that most reported AEs were non-serious and occurred within 30 days following vaccination. These findings support the known safety profile of DTaP vaccines and highlight identifiable timing patterns of AEs, which may help inform monitoring strategies and benefit-risk assessments after immunization.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"16 ","pages":"1733777"},"PeriodicalIF":4.8,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12907357/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146212661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Pseudorabies virus (PRV), a significant pathogen of swine, causes substantial economic losses, and even poses an emergent public health concern due to its zoonotic potential. The continuous evolution of PRV has undermined the effectiveness of current vaccines and antiviral drugs. Consequently, there is an urgent need to develop novel strategies to curb its spread.
Methods: The inhibitory effect of garcinone C on PRV replication was assessed in vivo and in vitro. To determine the stage of antiviral action, treatments were administered at different time points: pre-treatment, co-treatment, and post-infection. RNA sequencing was performed, and differentially expressed genes (DEGs) were identified.
Results: In the study, we found that garcinone C inhibited PRV replication in a concentration- and timedependent manner in vitro. The antiviral activity of garcinone C was specific to post-infection administration and did not extend to pre-treatment and cotreatment conditions. Transcriptomic analysis identified DEGs between garcinone C- and vehicle-treated cells after PRV infection. KEGG pathway enrichment analysis of the DEGs indicated that the antiviral effect of garcinone C was primarily associated with the PI3K-Akt signaling pathway, potentially through the downregulation of the host epidermal growth factor. Furthermore, garcinone C suppressed the production of key inflammatory cytokines such as IL-6, IL-8, and TNF-a during PRV infection. Oral administration of garcinone C conferred protection in PRVinfected mice, leading to attenuated weight loss, an improved survival rate, as well as reduced pathological changes and viral loads in tissues.
Discussion: Collectively, our findings identify garcinone C as a promising therapeutic candidate against PRV and elucidate its underlying molecular mechanism.
{"title":"Garcinone C inhibits pseudorabies virus replication through EGF/PI3K/Akt axis.","authors":"Changjie Lv, Shuang Wang, Zhongyuan Jin, Jiaxin Zhang, Yajie Peng, Jinmiao Chen","doi":"10.3389/fcimb.2025.1722752","DOIUrl":"https://doi.org/10.3389/fcimb.2025.1722752","url":null,"abstract":"<p><strong>Introduction: </strong>Pseudorabies virus (PRV), a significant pathogen of swine, causes substantial economic losses, and even poses an emergent public health concern due to its zoonotic potential. The continuous evolution of PRV has undermined the effectiveness of current vaccines and antiviral drugs. Consequently, there is an urgent need to develop novel strategies to curb its spread.</p><p><strong>Methods: </strong>The inhibitory effect of garcinone C on PRV replication was assessed <i>in vivo</i> and <i>in vitro</i>. To determine the stage of antiviral action, treatments were administered at different time points: pre-treatment, co-treatment, and post-infection. RNA sequencing was performed, and differentially expressed genes (DEGs) were identified.</p><p><strong>Results: </strong>In the study, we found that garcinone C inhibited PRV replication in a concentration- and timedependent manner in vitro. The antiviral activity of garcinone C was specific to post-infection administration and did not extend to pre-treatment and cotreatment conditions. Transcriptomic analysis identified DEGs between garcinone C- and vehicle-treated cells after PRV infection. KEGG pathway enrichment analysis of the DEGs indicated that the antiviral effect of garcinone C was primarily associated with the PI3K-Akt signaling pathway, potentially through the downregulation of the host epidermal growth factor. Furthermore, garcinone C suppressed the production of key inflammatory cytokines such as IL-6, IL-8, and TNF-a during PRV infection. Oral administration of garcinone C conferred protection in PRVinfected mice, leading to attenuated weight loss, an improved survival rate, as well as reduced pathological changes and viral loads in tissues.</p><p><strong>Discussion: </strong>Collectively, our findings identify garcinone C as a promising therapeutic candidate against PRV and elucidate its underlying molecular mechanism.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"15 ","pages":"1722752"},"PeriodicalIF":4.8,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12907380/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146212686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-02eCollection Date: 2026-01-01DOI: 10.3389/fcimb.2026.1734185
Yan Wang, Yun Diao, Tianqi Zhang, Fan Zhang, Wei Wang
Calf diarrhea is a common gastrointestinal disease that usually occurs within one month of birth. The disease causes the greatest economic losses to the cattle industry. Currently, a variety of diagnostic methods have been developed for calf diarrhea infections. However, existing methods are still unsatisfactory in terms of sensitivity, specificity, simplicity, cost, and speed.To provide a more sensitive, specific, simpler, and faster detection method, we recently developed an RPA-CRISPR/Cas12a assay that can detect BVDV, BCoV, BRV, and ETEC infections in cattle on-site. Testing for each pathogen is performed in a single test tube, without the need to open the tube in the middle, and can be completed in under 50 minutes.The RPA-CRISPR/Cas12a assay can detect BVDV, BCoV, BRV, and ETEC at concentrations of at least 10 copies/μL. The RPA-CRISPR/Cas12a assay does not produce false-positive results due to the presence of other pathogens. The sensitivity of BCoV, BRV, and ETEC in the RPA-CRISPR/Cas12a quadruple assay is equivalent to that of single qPCR. The sensitivity of BVDV in the quadruple assay is slightly lower than that of the single qPCR method.Due to its sensitivity, specificity, simplicity, and rapidity, the RPA-CRISPR/Cas12a assay is more practical for on-site detection of cattle diarrhea pathogens than any existing detection method.
{"title":"Sensitive, specific, and rapid on-site detection of calf diarrhea pathogens using the RPA-CRISPR/Cas 12a assay.","authors":"Yan Wang, Yun Diao, Tianqi Zhang, Fan Zhang, Wei Wang","doi":"10.3389/fcimb.2026.1734185","DOIUrl":"https://doi.org/10.3389/fcimb.2026.1734185","url":null,"abstract":"<p><p>Calf diarrhea is a common gastrointestinal disease that usually occurs within one month of birth. The disease causes the greatest economic losses to the cattle industry. Currently, a variety of diagnostic methods have been developed for calf diarrhea infections. However, existing methods are still unsatisfactory in terms of sensitivity, specificity, simplicity, cost, and speed.To provide a more sensitive, specific, simpler, and faster detection method, we recently developed an RPA-CRISPR/Cas12a assay that can detect BVDV, BCoV, BRV, and ETEC infections in cattle on-site. Testing for each pathogen is performed in a single test tube, without the need to open the tube in the middle, and can be completed in under 50 minutes.The RPA-CRISPR/Cas12a assay can detect BVDV, BCoV, BRV, and ETEC at concentrations of at least 10 copies/μL. The RPA-CRISPR/Cas12a assay does not produce false-positive results due to the presence of other pathogens. The sensitivity of BCoV, BRV, and ETEC in the RPA-CRISPR/Cas12a quadruple assay is equivalent to that of single qPCR. The sensitivity of BVDV in the quadruple assay is slightly lower than that of the single qPCR method.Due to its sensitivity, specificity, simplicity, and rapidity, the RPA-CRISPR/Cas12a assay is more practical for on-site detection of cattle diarrhea pathogens than any existing detection method.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"16 ","pages":"1734185"},"PeriodicalIF":4.8,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12907351/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146212829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Leptospirosis is a zoonotic disease caused by Leptospira interrogans and represents a major public health and veterinary concern. The persistence of the pathogen is closely associated with biofilm formation, yet targeted therapeutics are currently unavailable. The GroEL chaperonin, a conserved protein involved in biofilm formation and immunogenicity, was investigated as a potential therapeutic target.
Methods: A structure-based virtual screening approach was performed using a library of 543,503 natural compounds from the Life Chemicals database. Top-ranked ligands were evaluated using molecular docking and physicochemical and pharmacokinetic property analyses. Density functional theory calculations were performed to assess electronic stability, followed by molecular dynamics simulations to evaluate ligand-protein complex stability. Principal component analysis and MM-PBSA binding free energy calculations were subsequently applied to characterize conformational dynamics and binding affinity.
Results: Five compounds (F3385-2019, F1243-0200, F3139-0927, F2801-0179, and F1864-0208) exhibited strong binding affinities toward GroEL, with docking energies ranging from -10.34 to -8.26 kcal/mol. All shortlisted compounds complied with Lipinski's Rule of Five and demonstrated favorable pharmacokinetic properties. Molecular dynamics simulations and MM-PBSA analyses indicated stable ligand-protein interactions. Among the candidates, F1864-0208 and F1243-0200 emerged as the most stable and promising leads, whereas the remaining compounds showed moderate inhibition.
Discussion: This study provides computational evidence supporting GroEL as a viable drug target in L. interrogans. The identified natural compounds may represent promising scaffolds for the development of novel anti-leptospiral agents. Further in vitro and in vivo studies are required to validate their therapeutic efficacy and safety.
{"title":"Computational identification of natural inhibitors targeting GroEL in <i>Leptospira interrogans</i>: an integrative virtual screening and molecular dynamics approach.","authors":"Guneswar Sethi, Sthitaprajna Sahoo, Su-Cheol Han, Donghyun Shin, Jeong Ho Hwang","doi":"10.3389/fcimb.2025.1733096","DOIUrl":"https://doi.org/10.3389/fcimb.2025.1733096","url":null,"abstract":"<p><strong>Introduction: </strong>Leptospirosis is a zoonotic disease caused by <i>Leptospira interrogans</i> and represents a major public health and veterinary concern. The persistence of the pathogen is closely associated with biofilm formation, yet targeted therapeutics are currently unavailable. The GroEL chaperonin, a conserved protein involved in biofilm formation and immunogenicity, was investigated as a potential therapeutic target.</p><p><strong>Methods: </strong>A structure-based virtual screening approach was performed using a library of 543,503 natural compounds from the Life Chemicals database. Top-ranked ligands were evaluated using molecular docking and physicochemical and pharmacokinetic property analyses. Density functional theory calculations were performed to assess electronic stability, followed by molecular dynamics simulations to evaluate ligand-protein complex stability. Principal component analysis and MM-PBSA binding free energy calculations were subsequently applied to characterize conformational dynamics and binding affinity.</p><p><strong>Results: </strong>Five compounds (F3385-2019, F1243-0200, F3139-0927, F2801-0179, and F1864-0208) exhibited strong binding affinities toward GroEL, with docking energies ranging from -10.34 to -8.26 kcal/mol. All shortlisted compounds complied with Lipinski's Rule of Five and demonstrated favorable pharmacokinetic properties. Molecular dynamics simulations and MM-PBSA analyses indicated stable ligand-protein interactions. Among the candidates, F1864-0208 and F1243-0200 emerged as the most stable and promising leads, whereas the remaining compounds showed moderate inhibition.</p><p><strong>Discussion: </strong>This study provides computational evidence supporting GroEL as a viable drug target in <i>L. interrogans</i>. The identified natural compounds may represent promising scaffolds for the development of novel anti-leptospiral agents. Further <i>in vitro</i> and <i>in vivo</i> studies are required to validate their therapeutic efficacy and safety.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"15 ","pages":"1733096"},"PeriodicalIF":4.8,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12907346/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146212679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: To explore the clinical significance of metagenomic next-generation sequencing (mNGS) technology in diagnosing and treating periprosthetic joint infection (PJI) following total hip arthroplasty (THA).
Methods: From September 2018 to September 2024, 15 patients with periprosthetic infection after total hip arthroplasty were admitted. There were 11 males and 4 females; ages ranged from 28 to 87 years old, with an average of 63 years old. Infection occurred 6 to 42 months after total hip arthroplasty, with an average of 22.7 months. The infection lasted between 15 and 115 days, averaging 37.6 days. After being admitted to the hospital, joint fluid was collected for bacterial culture and mNGS. Following admission, joint fluid was collected for bacterial culture and mNGS, and antibiotics were adjusted based on the results, with surgery used to control the infection if needed.
Results: Bacterial culture method was positive in 10 cases (66.7%), with a total of 12 pathogenic bacteria types detected. MNGS was positive in 15 cases (100.0%), with a total of 19 pathogenic bacteria types detected. There was a statistically significant difference in the positive rate between the two methods (P < 0.05). Out of the 10 patients, 5 who tested positive using both the bacterial culture method and mNGS test showed identical pathogenic bacterial types, resulting in a 50.0% compliance rate. The testing time (from sample delivery to results) was (3.07 ± 0.96) days for bacterial culture method and (1.67 ± 0.49) days for mNGS test, and the difference was statistically significant (t=5.03, P<0.001). The patients were followed up for 13 to 82 months, with a mean of 40.7 months. In one patient, the infection returned three months after undergoing one-stage revision surgery, while the other 14 patients showed no signs of infection, resulting in an infection control rate of 93.3%.
Conclusion: MNGS can detect the pathogenic bacteria of postoperative PJI after THA more quickly and accurately than the bacterial culture method, which is crucial for guiding antibiotic and surgical treatment combinations for patients with postoperative PJI after THA.
{"title":"Investigating the benefits of metagenomic next-generation sequencing for patients experiencing infections after total hip replacement surgery: a retrospective cohort study with a minimum of one year of follow-up.","authors":"Jiaqing Zhu, Tianwei Xia, Lu Wang, Xindong Yin, Yong Ma, Jirong Shen","doi":"10.3389/fcimb.2026.1735867","DOIUrl":"https://doi.org/10.3389/fcimb.2026.1735867","url":null,"abstract":"<p><strong>Objective: </strong>To explore the clinical significance of metagenomic next-generation sequencing (mNGS) technology in diagnosing and treating periprosthetic joint infection (PJI) following total hip arthroplasty (THA).</p><p><strong>Methods: </strong>From September 2018 to September 2024, 15 patients with periprosthetic infection after total hip arthroplasty were admitted. There were 11 males and 4 females; ages ranged from 28 to 87 years old, with an average of 63 years old. Infection occurred 6 to 42 months after total hip arthroplasty, with an average of 22.7 months. The infection lasted between 15 and 115 days, averaging 37.6 days. After being admitted to the hospital, joint fluid was collected for bacterial culture and mNGS. Following admission, joint fluid was collected for bacterial culture and mNGS, and antibiotics were adjusted based on the results, with surgery used to control the infection if needed.</p><p><strong>Results: </strong>Bacterial culture method was positive in 10 cases (66.7%), with a total of 12 pathogenic bacteria types detected. MNGS was positive in 15 cases (100.0%), with a total of 19 pathogenic bacteria types detected. There was a statistically significant difference in the positive rate between the two methods (P < 0.05). Out of the 10 patients, 5 who tested positive using both the bacterial culture method and mNGS test showed identical pathogenic bacterial types, resulting in a 50.0% compliance rate. The testing time (from sample delivery to results) was (3.07 ± 0.96) days for bacterial culture method and (1.67 ± 0.49) days for mNGS test, and the difference was statistically significant (t=5.03, P<0.001). The patients were followed up for 13 to 82 months, with a mean of 40.7 months. In one patient, the infection returned three months after undergoing one-stage revision surgery, while the other 14 patients showed no signs of infection, resulting in an infection control rate of 93.3%.</p><p><strong>Conclusion: </strong>MNGS can detect the pathogenic bacteria of postoperative PJI after THA more quickly and accurately than the bacterial culture method, which is crucial for guiding antibiotic and surgical treatment combinations for patients with postoperative PJI after THA.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"16 ","pages":"1735867"},"PeriodicalIF":4.8,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12907442/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146212713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-02eCollection Date: 2026-01-01DOI: 10.3389/fcimb.2026.1757780
Yan Liu, Lei Liu, Jinbing Du, Wenxu Ni, Tingting Zou, Zihan Yuan, Yingkai Xu, Junying Li, Mengyu Shen, Yong Qi, Wanbing Liu
Platelet-rich plasma (PRP) is known as an autologous biological agent that can immensely promote wound healing. Bacterial infection is a common complication of wounds which obstructs wound healing. However, the effect of PRP on bacteria is still inconclusive. This in vitro study evaluated the antibacterial activity of PRP, platelet-poor plasma (PPP) and Frozen-PRP (Fro-PRP) against Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Staphylococcus aureus, and Enterococcus faecalis. The antimicrobial activity was performed using modified agar diffusion method, colony-forming units counting test, and bacterial growth curve analysis. The results showed that PRP, PPP and Fro-PRP had antimicrobial effects on five bacterial strains including Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Staphylococcus aureus, and Enterococcus faecalis. The antimicrobial activity of PRP was significantly stronger than that of Fro-PRP and PPP. To a certain extent, frozen storage may reduce the antibacterial ability of PRP. Overall, our study demonstrates that PRP and other platelet derived products seem to be a promising alternative tool for infected wounds treatment.
{"title":"<i>In vitro</i> antibacterial activity of platelet-rich plasma against Gram-positive and Gram-negative pathogens.","authors":"Yan Liu, Lei Liu, Jinbing Du, Wenxu Ni, Tingting Zou, Zihan Yuan, Yingkai Xu, Junying Li, Mengyu Shen, Yong Qi, Wanbing Liu","doi":"10.3389/fcimb.2026.1757780","DOIUrl":"https://doi.org/10.3389/fcimb.2026.1757780","url":null,"abstract":"<p><p>Platelet-rich plasma (PRP) is known as an autologous biological agent that can immensely promote wound healing. Bacterial infection is a common complication of wounds which obstructs wound healing. However, the effect of PRP on bacteria is still inconclusive. This <i>in vitro</i> study evaluated the antibacterial activity of PRP, platelet-poor plasma (PPP) and Frozen-PRP (Fro-PRP) against <i>Escherichia coli</i>, <i>Klebsiella pneumoniae</i>, <i>Enterobacter cloacae</i>, <i>Staphylococcus aureus</i>, and <i>Enterococcus faecalis</i>. The antimicrobial activity was performed using modified agar diffusion method, colony-forming units counting test, and bacterial growth curve analysis. The results showed that PRP, PPP and Fro-PRP had antimicrobial effects on five bacterial strains including <i>Escherichia coli</i>, <i>Klebsiella pneumoniae</i>, <i>Enterobacter cloacae</i>, <i>Staphylococcus aureus</i>, and <i>Enterococcus faecalis</i>. The antimicrobial activity of PRP was significantly stronger than that of Fro-PRP and PPP. To a certain extent, frozen storage may reduce the antibacterial ability of PRP. Overall, our study demonstrates that PRP and other platelet derived products seem to be a promising alternative tool for infected wounds treatment.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"16 ","pages":"1757780"},"PeriodicalIF":4.8,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12907390/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146212725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-02eCollection Date: 2026-01-01DOI: 10.3389/fcimb.2026.1662777
Min Jiang, Qian Sun, Xuedan Qiu, Qianru Mei, Yanye Tu, Feng Wang, Qingcao Li
Background: Pediatric acute respiratory tract infection (ARTI) constitutes a major global health threat. Since 2020, global containment measures have disrupted pathogen circulation patterns, leading to altered epidemiological profiles across multiple pathogens with marked regional heterogeneity. Current research in Ningbo predominantly focuses on single-pathogen surveillance or short-term monitoring, lacking systematic analysis of multi-pathogen interactive dynamics, age-specific susceptibility mechanisms, and co-infections.
Methods: Clinical data from all 191,967 pediatric patients with ARTI at Ningbo LiHuili Hospital (2020-2024) were collected. Laboratory testing including influenza A/B virus (IFV-A/B) detection, Mycoplasma pneumoniae (MP) testing, 13 respiratory pathogens analysis, and bacterial culture was systematically integrated and analyzed.
Results: From 2020 and 2024, the number of ARTI cases initially increased and then decreased, peaking in 2023. The incidence was highest in autumn and lowest in summer. Among all cases, 75,001 (39.07%) were diagnosed with acute lower respiratory infection (ALRI), with children aged 6 years exhibiting the highest susceptibility. Of the 41,766 cases tested, the overall pathogen detection rate was 67.61%. IFV-A/B, Human Parainfluenza Virus (HPIV), and Human Adenovirus (HAdV) were more frequently detected in acute upper respiratory tract infections (AURI) (P < 0.05), while Human Rhinovirus (HRV), Respiratory Syncytial Virus (RSV), and MP were predominantly identified in ALRI cases (P < 0.05). Each pathogen exhibited age-specific susceptibility patterns. Several pathogens, such as IFV-A, MP, and HAdV, displayed distinctive epidemic peaks. Co-infections were common, with a 17.38% co-infection rate observed in the group tested for 13 respiratory pathogens, and a higher co-infection rate of 39.49% when testing combined respiratory pathogens and bacteria. Correlation analysis among pathogens revealed predominant antagonistic interactions between viruses, positive associations among bacteria, and generally positive interactions between viruses and bacteria, though overall correlation strengths were weak.
Conclusion: Pediatric ARTI exhibit age-specific susceptibility and pathogen variation. The 2023-2024 resurgence demands precision control strategies for optimized intervention.
{"title":"Multi-dimensional epidemiology of pediatric acute respiratory tract infection in Ningbo, China (2020-2024): age-specific susceptibility, pathogen dynamics, and epidemiological trends.","authors":"Min Jiang, Qian Sun, Xuedan Qiu, Qianru Mei, Yanye Tu, Feng Wang, Qingcao Li","doi":"10.3389/fcimb.2026.1662777","DOIUrl":"https://doi.org/10.3389/fcimb.2026.1662777","url":null,"abstract":"<p><strong>Background: </strong>Pediatric acute respiratory tract infection (ARTI) constitutes a major global health threat. Since 2020, global containment measures have disrupted pathogen circulation patterns, leading to altered epidemiological profiles across multiple pathogens with marked regional heterogeneity. Current research in Ningbo predominantly focuses on single-pathogen surveillance or short-term monitoring, lacking systematic analysis of multi-pathogen interactive dynamics, age-specific susceptibility mechanisms, and co-infections.</p><p><strong>Methods: </strong>Clinical data from all 191,967 pediatric patients with ARTI at Ningbo LiHuili Hospital (2020-2024) were collected. Laboratory testing including influenza A/B virus (IFV-A/B) detection, <i>Mycoplasma pneumoniae</i> (MP) testing, 13 respiratory pathogens analysis, and bacterial culture was systematically integrated and analyzed.</p><p><strong>Results: </strong>From 2020 and 2024, the number of ARTI cases initially increased and then decreased, peaking in 2023. The incidence was highest in autumn and lowest in summer. Among all cases, 75,001 (39.07%) were diagnosed with acute lower respiratory infection (ALRI), with children aged 6 years exhibiting the highest susceptibility. Of the 41,766 cases tested, the overall pathogen detection rate was 67.61%. IFV-A/B, Human Parainfluenza Virus (HPIV), and Human Adenovirus (HAdV) were more frequently detected in acute upper respiratory tract infections (AURI) (<i>P</i> < 0.05), while Human Rhinovirus (HRV), Respiratory Syncytial Virus (RSV), and MP were predominantly identified in ALRI cases (<i>P</i> < 0.05). Each pathogen exhibited age-specific susceptibility patterns. Several pathogens, such as IFV-A, MP, and HAdV, displayed distinctive epidemic peaks. Co-infections were common, with a 17.38% co-infection rate observed in the group tested for 13 respiratory pathogens, and a higher co-infection rate of 39.49% when testing combined respiratory pathogens and bacteria. Correlation analysis among pathogens revealed predominant antagonistic interactions between viruses, positive associations among bacteria, and generally positive interactions between viruses and bacteria, though overall correlation strengths were weak.</p><p><strong>Conclusion: </strong>Pediatric ARTI exhibit age-specific susceptibility and pathogen variation. The 2023-2024 resurgence demands precision control strategies for optimized intervention.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"16 ","pages":"1662777"},"PeriodicalIF":4.8,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12907365/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146212656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}